PDB Short entry for 2IC4
HEADER    IMMUNE SYSTEM                           12-SEP-06   2IC4              
TITLE     SOLUTION STRUCTURE OF THE HIS402 ALLOTYPE OF THE FACTOR H SCR6-SCR7-  
TITLE    2 SCR8 FRAGMENT                                                        
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: COMPLEMENT FACTOR H;                                       
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: FACTOR H SCR6-SCR7-SCR8;                                   
COMPND   5 SYNONYM: H FACTOR 1;                                                 
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: CFH, HF, HF1;                                                  
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;                            
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 511693;                                     
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: BL21;                                      
SOURCE   9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  10 EXPRESSION_SYSTEM_PLASMID: PET14B                                    
KEYWDS    FACTOR H, X-RAY SCATTERING, HOMOLOGY MODELLING, ULTRACENTRIFUGATION,  
KEYWDS   2 IMMUNE SYSTEM                                                        
EXPDTA    SOLUTION SCATTERING                                                   
MDLTYP    CA ATOMS ONLY; CA ATOMS ONLY, CHAIN A                                 
AUTHOR    A.N.FERNANDO,P.B.FURTADO,H.E.GILBERT,S.J.CLARK,A.J.DAY,R.B.SIM,       
AUTHOR   2 S.J.PERKINS                                                          
REVDAT   6   21-FEB-24 2IC4    1       SEQADV                                   
REVDAT   5   18-OCT-17 2IC4    1       REMARK                                   
REVDAT   4   07-APR-10 2IC4    1       REMARK                                   
REVDAT   3   24-FEB-09 2IC4    1       VERSN                                    
REVDAT   2   24-APR-07 2IC4    1       JRNL                                     
REVDAT   1   10-APR-07 2IC4    0                                                
JRNL        AUTH   A.N.FERNANDO,P.B.FURTADO,S.J.CLARK,H.E.GILBERT,A.J.DAY,      
JRNL        AUTH 2 R.B.SIM,S.J.PERKINS                                          
JRNL        TITL   ASSOCIATIVE AND STRUCTURAL PROPERTIES OF THE REGION OF       
JRNL        TITL 2 COMPLEMENT FACTOR H ENCOMPASSING THE TYR402HIS               
JRNL        TITL 3 DISEASE-RELATED POLYMORPHISM AND ITS INTERACTIONS WITH       
JRNL        TITL 4 HEPARIN.                                                     
JRNL        REF    J.MOL.BIOL.                   V. 368   564 2007              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   17362990                                                     
JRNL        DOI    10.1016/J.JMB.2007.02.038                                    
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   M.ASLAM,S.J.PERKINS                                          
REMARK   1  TITL   FOLDED-BACK SOLUTION STRUCTURE OF MONOMERIC FACTOR H OF      
REMARK   1  TITL 2 HUMAN COMPLEMENT BY SYNCHROTRON X-RAY AND NEUTRON            
REMARK   1  TITL 3 SCATTERING, ANALYTICAL ULTRACENTRIFUGATION AND CONSTRAINED   
REMARK   1  TITL 4 MOLECULAR MODELLING                                          
REMARK   1  REF    J.MOL.BIOL.                   V. 309  1117 2001              
REMARK   1  REFN                   ISSN 0022-2836                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : INSIGHTII 98                                         
REMARK   3   AUTHORS     :                                                      
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 187                                     
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 0                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2IC4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-DEC-06.                  
REMARK 100 THE DEPOSITION ID IS D_1000039399.                                   
REMARK 265                                                                      
REMARK 265 EXPERIMENTAL DETAILS                                                 
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING                       
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : ESRF GRENOBLE           
REMARK 265   SYNCHROTRON (Y/N)                        : Y                       
REMARK 265   BEAMLINE TYPE                            : IDO2                    
REMARK 265   BEAMLINE INSTRUMENT                      : NULL                    
REMARK 265   DETECTOR TYPE                            : FRELON CCD CAMERA       
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 288                     
REMARK 265   PH                                       : 7.3                     
REMARK 265   NUMBER OF TIME FRAMES USED               : 10                      
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 0.38-0.55               
REMARK 265   SAMPLE BUFFER                            : 9.6 MM NA, K            
REMARK 265                                              PHOSPHATE 137 MM NACL   
REMARK 265                                              3 MM KCL 8 MM NA2HPO4   
REMARK 265                                              1 MM KH2PO4             
REMARK 265   DATA REDUCTION SOFTWARE                  : MULTICCD                
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 3.12                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.16                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 1.04                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.06                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : NULL                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 0.5                     
REMARK 265                                                                      
REMARK 265 DATA ANALYSIS AND MODEL FITTING:                                     
REMARK 265  METHOD USED TO DETERMINE THE STRUCTURE: NULL                        
REMARK 265  SOFTWARE USED    : INSIGHT II, SCTPL7, GNOM                         
REMARK 265  SOFTWARE AUTHORS : NULL                                             
REMARK 265  STARTING MODEL   : NULL                                             
REMARK 265                                                                      
REMARK 265 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 265 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 265 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 265                                                                      
REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL                
REMARK 265                                                                      
REMARK 265  OTHER DETAILS: THE INFORMATION FOR THE HIS402 ALLOTYPE IS LISTED    
REMARK 265  FIRST IN REMARK 265. THE INFORMATION FOR THE TYR402 ALLOTYPE IS     
REMARK 265  LISTED SECOND. THE COORDINATES CONTAIN ONLY CA ATOMS. THE SECOND    
REMARK 265  SET OF RADII: MEAN RADIUS OF GYRATION IS 3.26 NM WITH SIGMA MEAN    
REMARK 265  0.20. R MEAN CROSS SECTIONAL RADII IS 1.15 NM WITH SIGMA MEAN       
REMARK 265  0.13.                                                               
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   CA   PRO A   324     CA   VAL A   347              1.42            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1HAQ   RELATED DB: PDB                                   
REMARK 900 HUMAN FACTOR H                                                       
DBREF  2IC4 A  321   506  UNP    P08603   CFAH_HUMAN     321    506             
SEQADV 2IC4 GLY A  320  UNP  P08603              CLONING ARTIFACT               
SEQADV 2IC4 TYR A  402  UNP  P08603    HIS   402 MICROHETEROGENEITY             
SEQRES   1 A  187  GLY THR LEU LYS PRO CYS ASP TYR PRO ASP ILE LYS HIS          
SEQRES   2 A  187  GLY GLY LEU TYR HIS GLU ASN MET ARG ARG PRO TYR PHE          
SEQRES   3 A  187  PRO VAL ALA VAL GLY LYS TYR TYR SER TYR TYR CYS ASP          
SEQRES   4 A  187  GLU HIS PHE GLU THR PRO SER GLY SER TYR TRP ASP HIS          
SEQRES   5 A  187  ILE HIS CYS THR GLN ASP GLY TRP SER PRO ALA VAL PRO          
SEQRES   6 A  187  CYS LEU ARG LYS CYS TYR PHE PRO TYR LEU GLU ASN GLY          
SEQRES   7 A  187  TYR ASN GLN ASN TYR GLY ARG LYS PHE VAL GLN GLY LYS          
SEQRES   8 A  187  SER ILE ASP VAL ALA CYS HIS PRO GLY TYR ALA LEU PRO          
SEQRES   9 A  187  LYS ALA GLN THR THR VAL THR CYS MET GLU ASN GLY TRP          
SEQRES  10 A  187  SER PRO THR PRO ARG CYS ILE ARG VAL LYS THR CYS SER          
SEQRES  11 A  187  LYS SER SER ILE ASP ILE GLU ASN GLY PHE ILE SER GLU          
SEQRES  12 A  187  SER GLN TYR THR TYR ALA LEU LYS GLU LYS ALA LYS TYR          
SEQRES  13 A  187  GLN CYS LYS LEU GLY TYR VAL THR ALA ASP GLY GLU THR          
SEQRES  14 A  187  SER GLY SER ILE THR CYS GLY LYS ASP GLY TRP SER ALA          
SEQRES  15 A  187  GLN PRO THR CYS ILE                                          
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000